VIOV:NYE-Vanguard S&P Small-Cap 600 Value Index Fund ETF Shares (USD)

ETF | Small Value |

Last Closing

USD 92.23

Change

-0.18 (-0.19)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

-0.38 (-0.19%)

USD 30.69B
IJS iShares S&P Small-Cap 600 Valu..

-0.33 (-0.31%)

USD 6.99B
DES WisdomTree U.S. SmallCap Divid..

-0.16 (-0.46%)

USD 2.09B
XSVM Invesco S&P SmallCap Value wit..

-0.59 (-1.08%)

USD 0.80B
XSLV Invesco S&P SmallCap Low Volat..

-0.15 (-0.31%)

USD 0.31B
RZV Invesco S&P SmallCap 600® Pur..

-0.95 (-0.87%)

N/A
JKL iShares Morningstar Small-Cap ..

N/A

N/A
SLYV SPDR® S&P 600 Small Cap Value..

-0.30 (-0.35%)

N/A
FDM First Trust Dow Jones Select M..

-0.07 (-0.11%)

N/A
PXSV Invesco S&P SmallCap Value wit..

-0.59 (-1.08%)

N/A

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -47.89% 45% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.89% 45% F 16% F
Trailing 12 Months  
Capital Gain -36.06% 38% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.06% 38% F 16% F
Trailing 5 Years  
Capital Gain -30.14% 46% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.14% 46% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain 12.95% 54% F 73% C
Dividend Return 14.65% 54% F 72% C
Total Return 1.70% 85% B 40% F
Risk Return Profile  
Volatility (Standard Deviation) 32.02% 54% F 32% F
Risk Adjusted Return 45.76% 54% F 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike